science

Gerstmann–Sträussler–Scheinker syndrome

Gerstmann–Sträussler–Scheinker syndrome is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Gerstmann–Sträussler–Scheinker syndrome rather than just read about it. In short: Gerstmann–Sträussler–Scheinker syndrome (GSS) is an extremely rare, invariably fatal neurodegenerative disease that usually affects patients from 35 to 55 years in age. It is exclusively heritable in an autosomal dominant manner, and is found in only a few families around the world.

Key takeaways

Gerstmann–Sträussler–Scheinker syndrome belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Gerstmann–Sträussler–Scheinker syndrome to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Gerstmann–Sträussler–Scheinker syndrome from memory before moving on to harder problems.

Reference excerpt

Gerstmann–Sträussler–Scheinker syndrome (GSS) is an extremely rare, invariably fatal neurodegenerative disease that usually affects patients from 35 to 55 years in age. It is exclusively heritable in an autosomal dominant manner, and is found in only a few families around the world. GSS is considered a transmissible spongiform encephalopathy (TSE) due to the causative role played by the PRNP gene, which encodes for the human prion protein. It was discovered by Josef Gerstmann, Ernst Sträussler, and Ilya Scheinker in 1936. Certain symptoms are common to GSS, such as progressive ataxia, pyramidal signs, and dementia; they worsen as the disease progresses. Much like Creutzfeldt-Jakob disease, Gerstmann–Sträussler–Scheinker syndrome has significant variety in presentation.

Symptoms and signs Symptoms start with slowly developing dysarthria (difficulty speaking) and cerebellar truncal ataxia (unsteadiness) before the progressive dementia becomes more evident. In the early stages of GSS, people with the condition may also exhibit clumsiness and difficulty walking. As the condition progresses, symptoms of ataxia become more pronounced. Loss of memory can be the first symptom of GSS. Extrapyramidal and pyramidal symptoms and signs may occur, and the disease may mimic spinocerebellar ataxias in the beginning stages. Myoclonus (spasmodic muscle contraction) is less frequently seen than in Creutzfeldt–Jakob disease. Many patients also exhibit nystagmus (involuntary movement of the eyes), visual disturbances, and blindness or deafness. The neuropathological findings of GSS include widespread deposition of amyloid plaques composed of misfolded prion proteins. Four clinical phenotypes are recognized: typical GSS, GSS with areflexia and paresthesia, pure dementia GSS and Creutzfeldt-Jakob disease-like GSS.

Causes GSS is part of a group of diseases called transmissible spongiform encephalopathies. These diseases are caused by prions, which are a class of pathogenic proteins that are resistant to proteases. These prions then form clusters in the brain, which are responsible for the neurodegenerative effects seen in patients. The P102L mutation, which causes a substitution of proline to a leucine in codon 102, has been found in the prion protein gene (PRNP, on chromosome 20) of most affected individuals. Therefore, it appears this genetic change is usually required for the development of the disease.

Diagnosis GSS can be identified through genetic testing. Testing for GSS involves a blood and DNA examination in order to detect the mutated gene at certain codons. If the genetic mutation is present, the patient will eventually develop GSS.

Treatment There is no cure for GSS, nor is there any known treatment to slow the progression of the disease. Therapies and medication are aimed at treating or slowing down the effects of the symptoms. The goal of these symptomatic treatments is to try to improve the patient's quality of life as much as possible. There is some ongoing research to find a cure, with one of the most prominent examples being the PRN100 monoclonal antibody.

Prognosis GSS is a disease that progresses slowly, lasting from roughly 2 to 10 years, with an average of approximately five years. Symptoms, such as clumsiness and unsteadiness when walking, appear at the beginning of the illness. Muscle jerking (myoclonus) is much less common than in Creutzfeldt-Jakob disease. Speaking becomes difficult (called dysarthria), and dementia develops. Nystagmus (rapid movement of the eyes in one direction, followed by a slower drift back to the original position) and deafness may develop. Muscle coordination is lost (called ataxia), which may cause muscles to become stiff. Usually, the muscles that control breathing and coughing are impaired, resulting in a high risk of pneumonia, which is the most common cause of death. The disease ultimately results in death, most commonly from the patient either going into a coma, or from a secondary infection due to the patient's loss of bodily functions.

Research Prion diseases, also called transmissible spongiform encephalopathies (TSEs), are neurodegenerative diseases of the brain thought to be caused by a protein that converts to an abnormal form called a prion. GSS is a very rare TSE, making its genetic origin nearly impossible to determine. It is also challenging to find any patients with GSS, as the disease tends to be underreported, due to its clinical similarity to other diseases, and has been found in only a few countries. In 1989, the first mutation of the prion protein gene was identified in a GSS family. The largest of these families affected by GSS is the Indiana Kindred, spanning over 8 generations, and includes over 3,000 people, with 57 individuals known to be affected. GSS was later realized to have many different gene mutation types, varying in symptom severity, timing and progression. Doctors in different parts of the world are in the process of uncovering more generations and families who have the mutation.

Notes

External links Gerstmann–Sträussler–Scheinker syndrome Archived 2013-05-11 at the Wayback Machine, MedicineNet.com ITALIAN ASSOCIATION AGAINST GERSTMANN STRAUSSLER SCHEINKER'S DISEASE Archived 2023-05-28 at the Wayback Machine

Illustrations

Worked examples

Example 1 — a first encounter with Gerstmann–Sträussler–Scheinker syndrome

Start with the simplest possible case. Write down what Gerstmann–Sträussler–Scheinker syndrome claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Gerstmann–Sträussler–Scheinker syndrome before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Gerstmann–Sträussler–Scheinker syndrome ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Gerstmann–Sträussler–Scheinker syndrome

In research: Gerstmann–Sträussler–Scheinker syndrome appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Gerstmann–Sträussler–Scheinker syndrome in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Gerstmann–Sträussler–Scheinker syndrome is common in secondary-school and first-year university syllabi. It links to neighbouring topics Rare syndromes, Syndromes affecting the nervous system, Transmissible spongiform encephalopathies, so understanding it makes those chapters shorter.
In everyday life: Look for Gerstmann–Sträussler–Scheinker syndrome outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Gerstmann–Sträussler–Scheinker syndrome” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Gerstmann–Sträussler–Scheinker syndrome in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Gerstmann–Sträussler–Scheinker syndrome means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Gerstmann–Sträussler–Scheinker syndrome out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Gerstmann–Sträussler–Scheinker syndrome in simple terms?

Why does Gerstmann–Sträussler–Scheinker syndrome matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Gerstmann–Sträussler–Scheinker syndrome?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Gerstmann–Sträussler–Scheinker syndrome.